Seralutinib
Seralutinib is an inhibitor of inhaled PDGFRα and PDGFRβ. It is used in the study for pulmonary arterial hypertension.
Product Specifications
CAS Number
1619931-27-9
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
469.55
Molecular Formula
C27H27N5O3
Notes
Research use only, not for human use.
Receptor
PDGFRα|PDGFRβ
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog